Health Care & Life Sciences » Pharmaceuticals | Gennex Laboratories Ltd.

Gennex Laboratories Ltd. | Balance Sheet

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
3,683.40
5,564.80
8,477.70
6,295.20
10,182.70
Total Accounts Receivable
89,558.80
153,074.20
148,342.80
224,968.60
235,553.70
Inventories
68,322.20
13,021.10
30,264.10
30,462.30
30,255.00
Other Current Assets
1,650.30
1,439.80
2,538.40
703.60
628.20
Total Current Assets
163,214.70
173,099.90
189,623.00
262,429.70
276,619.60
Net Property, Plant & Equipment
161,067.70
147,019.80
155,791.70
157,411.40
155,813.30
Total Investments and Advances
71,589.10
71,761.00
70,100.00
70,055.50
70,005.30
Other Assets
19.10
163.00
2,397.50
2,214.30
2,221.50
Total Assets
395,890.70
392,043.60
417,912.20
492,110.90
504,659.70
ST Debt & Current Portion LT Debt
26,413.30
34,644.80
22,804.60
37,515.90
21,216.20
Accounts Payable
76,573.30
67,561.50
70,465.00
94,572.30
121,644.10
Income Tax Payable
3,100.00
3,760.00
6,700.00
3,963.40
3,414.60
Other Current Liabilities
17,148.10
19,280.00
24,265.40
35,346.80
30,345.40
Total Current Liabilities
123,234.80
125,246.30
124,235.00
171,398.50
176,620.30
Long-Term Debt
5,415.80
3,780.20
1,477.40
854.80
3,485.60
Provision for Risks & Charges
674.00
-
-
-
-
Deferred Taxes
12,699.70
7,758.90
9,830.90
9,488.80
6,051.90
Other Liabilities
-
-
-
1,001.10
826.90
Total Liabilities
142,024.30
136,785.40
135,543.40
182,743.30
186,984.70
Common Equity (Total)
251,866.40
253,258.20
280,368.90
307,367.60
315,675.10
Total Shareholders' Equity
251,866.40
253,258.20
280,368.90
307,367.60
315,675.10
Total Equity
251,866.40
253,258.20
280,368.90
307,367.60
315,675.10
Liabilities & Shareholders' Equity
395,890.70
392,043.60
417,912.20
492,110.90
504,659.70
Non-Equity Reserves
2,000.00
2,000.00
2,000.00
2,000.00
2,000.00

About Gennex Laboratories

View Profile
Address
Akash Ganga
Hyderabad TS 500073
India
Employees -
Website http://www.gennexlab.com
Updated 09/14/2018
Gennex Laboratories Ltd. engages in the manufacture of bulk drugs and intermediates products. It operates through the following geographical segments: Germany, Egypt, Iran, Peru, Bangladesh, Spain, Guatemala City, El Salvador, Vietnam, Export Others, and India. Its products include Guaifenesin, Methocarbamol, Phenazopyridine Hydrochloride, Fluconazole, Metformin Hcl, Ambroxol Hcl, and Melitracen Hydrochloride.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.